Back to Journals » Patient Preference and Adherence » Volume 9

Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients

Authors Gao Y, Gao F, Ma J, Zhang X, Li Y, Song L, Zhao D

Received 21 April 2015

Accepted for publication 12 June 2015

Published 19 August 2015 Volume 2015:9 Pages 1189—1194


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Naifeng Liu

Ying Gao,1,* Fei Gao,2,* Jin-lu Ma,1,* Xiao-zhi Zhang,1 Yi Li,1 Li-ping Song,1 Dong-li Zhao1

1Department of Radiotherapy Oncology, First Affiliated Hospital of Xi’an Jiaotong University, 2Department of Neurology, First Affiliated Hospital of Xi’an Medical University, Xi’an, People’s Republic of China

*These authors contributed equally to this work

Objective: Lung cancer is still the leading cause of cancer-related deaths worldwide. However, most elderly patients with advanced non-small-cell lung cancer (NSCLC) have been undertreated and the outcome related to age is controversial. A retrospective analysis was conducted for advanced NSCLC in order to investigate the characteristics and prognosis of older patients.
Methods: Medical records were collected from 165 patients with NSCLC (stages IIIA–IIIB) who had been treated with concurrent chemoradiotherapy (CRT) or radiotherapy from January 2009 to January 2011. The cases were divided into two age groups 1) patients ≥70 years old; 2) patients <70 years old. There were 73 patients in group I, 92 in group II. Patient characteristics, treatment toxicities, and prognosis were evaluated.
Results: Of the 165 patients analyzed, 34 patients (34/73) in group I received concurrent CRT while 47 (47/92) in group II completed that treatment. No significant difference was observed in the reason for patients who discontinued CRT in two groups (P>0.05). In the patients with adenocarcinoma, more cases were found in group II than that in group I; the more squamous cell carcinoma and the more smokers with squamous cell carcinoma were seen in older group (P<0.05). With a median follow-up of 20.5 months, the 1-year survival for group I and II were 49.3% and 40.2% respectively (P=0.243). Two-year survival for the two groups was 20.5% and 16.3% (P=0.483); 3-year survival was 9.6% and 9.8% (P=0.967). There was no significant difference between two groups statistically in survival by univariate analysis (P>0.05). The therapy-related toxicities in group I seem to be similar to the group II (P>0.05).
Conclusion: More adenocarcinoma patients were found in youthful lung cancer and the more smokers with squamous cell carcinoma were seen in older group. Age is not the important factor for the selection and allocation of treatment in advanced NSCLC. The same prognosis and toxicities had been shown in older and young. Age may not be an independent increased risk of death in advanced NSCLC.

Keywords: advanced non-small-cell lung cancer, age, prognosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Sphingosine kinase 1 as an anticancer therapeutic target

Gao Y, Gao F, Chen K, Tian ML, Zhao DL

Drug Design, Development and Therapy 2015, 9:3239-3245

Published Date: 23 June 2015

The potential clinical applications and prospects of microRNAs in lung cancer

Gao Y, Gao F, Ma JL, Sun WZ, Song LP

OncoTargets and Therapy 2014, 7:901-906

Published Date: 4 June 2014

Cerium oxide nanoparticles in cancer

Gao Y, Chen K, Ma JL, Gao F

OncoTargets and Therapy 2014, 7:835-840

Published Date: 27 May 2014

Intraoperative radiotherapy in stage IIB adenocarcinoma of the uterine cervix: a retrospective study

Gao Y, Liu Z, Gao F, Chen X

OncoTargets and Therapy 2013, 6:1695-1700

Published Date: 20 November 2013

Expression and prognostic relevance of MET and phospho-BAD in non-small cell lung cancer

Sun W, Ai T, Gao Y, Zhang Y, Cui J, Song L

OncoTargets and Therapy 2013, 6:1315-1323

Published Date: 18 September 2013

The evaluation of older patients with cervical cancer

Gao Y, Ma JL, Gao F, Song LP

Clinical Interventions in Aging 2013, 8:783-788

Published Date: 25 June 2013

Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancer

Gao Y, Gao F, Liu Z, Song LP

OncoTargets and Therapy 2013, 6:297-302

Published Date: 2 April 2013

Readers of this article also read:

Adherence to self-care in patients with heart failure in the HeartCycle study

Stut W, Deighan C, Cleland JG, Jaarsma T

Patient Preference and Adherence 2015, 9:1195-1206

Published Date: 19 August 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010